DOS BULLETIN - Dansk Ortopædisk Selskab
DOS BULLETIN - Dansk Ortopædisk Selskab
DOS BULLETIN - Dansk Ortopædisk Selskab
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
2010-378_<strong>DOS</strong> nr. 3 2010 29/09/10 10:08 Side 119<br />
Meta-analysis on risk of reinfection by one-stage vs.<br />
two-stage revision in chronically infected<br />
hip arthroplasties<br />
Jeppe Lange, Anders Troelsen, Kristian Larsen, Kjeld Søballe<br />
Lundbeck Foundation Center for Fast-track Hip and Knee Surgery &<br />
Orthopaedic dep. Regional Hospital; Orthopaedic dep. Hvidovre Hospital;<br />
Lundbeckfoundation Center for Fast-track Hip and Knee Surgery<br />
& Orthopaedic dep. Aarhus University<br />
Background: Internationally the two-stage revision is accepted as gold<br />
surgical standard for treating chronic infections following total hip<br />
arthroplasty (THA). Fast-track treatment is done by one-stage revision,<br />
which is advocated by some international centers. The optimal treatment<br />
strategy for chronically infected THA remains debated<br />
Purpose: We aimed to investigate if one-stage revision is a relevant<br />
treatment strategy, compared to two-stage revision in terms of risk of reinfection<br />
Methods: The meta-analysis was performed in accordance to PRISMA<br />
(www.prisma- statement.org). Studies were identified by searching<br />
Pubmed and Embase with bibliographic cross-reference. Studies were<br />
included for review if eligible according to specified criteria. Analysis<br />
was done using Comprehensive Meta- Analysis software version 2.0. We<br />
estimated risk of reinfections (95% confidence intervals) by randomeffects<br />
model. Statistical significance accepted at p< 0.05<br />
Findings: We used data from 36 eligible studies, pooling 1304 patients<br />
with chronically infected THA and 127 registered reinfections following<br />
reimplantation by either one- or two-stage revision. Reinfection occurs<br />
with an estimated risk of 11 % (9.6 – 13 %). Stratifying by treatment<br />
strategy, reinfection in one- stage revision occurs with an estimated risk<br />
of 13 % (10% -17%) and in two- stage with an estimated risk of 10%<br />
(8.5% - 13%) which did not differ significantly (p-value 0.173). Additional<br />
subgroup or sensitivity analysis did not alter this result. The<br />
methodological quality was considered low in all 36 studies<br />
Conclusion: Although two-stage revision is the gold standard in treating<br />
chronic infections in THA - the quality of evidence is generally poor –<br />
and showed no superiority over one-stage revision<br />
119